Ryanodine (RYA) at a low concentration (several tens of nM) is known to selectively bind to Ca2+ release channels in sarcoplasmic reticulum (SR) and to fix them open. The present study was designed to investigate the effects of the selective change in Ca2+ release channel activity on cardiac mechanoenergetics as a model of Ca2+-leaky SR observed in pathological hearts. We analyzed the negative inotropic effect of RYA at a low concentration (up to 30±13 nM) on left ventricular (LV) mechanoenergetics using frameworks of LV E.,, (a contractility index) and the myocardial oxygen consumption (LV V02)-systolic pressure-volume area (PVA) (a measure of total mechanical energy) relation in 11 isolated, blood-perfused dog hearts. RYA significantly decreased E.,. by 42%, whereas PVA-independent V02 remained disproportionately high (93% of control). This oxygen-wasting effect of RYA was quite different from ordinary inotropic drugs, which alter E.. and PVA-independent V02 proportionally. The present result suggests that RYA suppresses force generation of cardiac muscle for a given amount of total sequestered Ca2+ by SR in a similar way to myocardial ischemia and stunning. We speculate about the underlying mechanism that RYA makes SR leaky for Ca2+ and thereby wastes energy for Ca2+ handling by SR. (J. Clin. Emm means the "contractile efficiency" ( 14). V02 can be di-Oxygen-wasting Effect ofRyanodine 823 J. Clin. Invest.
Introduction
Recent studies have indicated that dysfunction in the Ca2+ transport system ofthe sarcoplasmic reticulum (SR)' plays an important role in pathophysiological states such as ischemic, acidotic, and stunned hearts ( 1-7). It has been proposed that dysfunction of not only Ca2+ uptake (2, 5) but also Ca2' release (2) (3) (4) and Ca2+ permeability of the SR ( 1 ) contribute to this SR dysfunction. The SR Ca2' release channel has been shown to have a single Ca2' release channel activity, which is 1. Abbreviations used in this paper: AVO2D, arteriovenous oxygen content difference; E,,.., contractile index; LV, left ventricular; P-V, pressure volume; PVA, pressure-volume area; RV, Right ventricle; RYA, ryanodine; SR, sarcoplasmic reticulum; V02, oxygen consumption. regulated by the cellular components such as Ca2", Mg2+, and ATP (8) (9) (10) (11) . Although SR Ca2+ release has been assumed to play a central role in the regulation of cardiac contractility in both physiological and pathophysiological states, the relationship between the change of the Ca2+ release channel activity and cardiac contractility is still unclear.
On the other hand, our studies on cardiac energetics have revealed a unique relationship between-cardiac contractility and energy utilization for excitation-contraction-relaxation coupling (13) (14) (15) (16) (17) (18) (19) (20) . Namely, increases in ventricular contractility by CaCl2, catecholamines, or other cardiotonic agents (OPC-8212 [15] , ouabain [16] ), denopamine [17] , and Amrinone [18]) linearly correlate with changes in the fraction of oxygen consumption that we consider primarily related to the total intracellular Ca2' handling sequestered by Ca2+pump ATPase and independent of mechanical contraction. Therefore, we consider that the determination of the nonmechanical energy consumption enables us to indirectly but quantitatively analyze changes in the total amount of calcium cycling with each beat (total Ca2+ handling) in myocardium under various inotropic interventions.
The present study was designed to investigate the effects of the selective change in Ca2+ release channel activity on cardiac mechanoenergetics in a ryanodine (RYA)-treated heart as a pathological heart model with Ca2+-leaky SR as observed in ischemic, acidotic, and stunned hearts (1) (2) (3) (4) (5) (6) (7) . RYA specifically binds to the open state Ca2+ release channel in cardiac SR, fixes it open at a low concentration (several tens ofnM), and makes SR leaky for Ca2+ (9) (10) (11) . We fully used the relationship between ventricular contractility and nonmechanical energy consumption in the excised, cross-circulated (blood-perfused) dog heart. We obtained results suggesting that the negative inotropism ofRYA primarily relates to suppression ofthe force generation ofcardiac muscle for a given amount oftotal sequestered Ca2+ by SR.
Theoretical considerations
Left ventricular contractile index (LV E.) and the myocardial oxygen consumption-systolic pressure-volume area (LV V02-PVA) relationship have the following physiological significance: E.,,. the slope of the end-systolic pressure-volume (P-V) relation, sensitively reflects ventricular contractility practically independent of ventricular loading conditions except for a situation with large changes in ejection fraction ( Fig. 1 A) ( 12, 14, 21, 22) . PVA is a measure of the total mechanical energy generated by a ventricular contraction. PVA is quantified by the area in the P-V diagram that is bounded by the end-systolic P-V relation line, end-diastolic P-V relation curve, and systolic P-V trajectory ( Fig. 1 A) (12) (13) (14) . In a stable contractile state, PVA linearly correlates with LV V02 in a load-independent manner in a stable contractile state ( Fig. 1 B) Figure 1 . Schematic illustration of LV systolic pressure-volume area (PVA, A), LV V02-PVA relation in the volume-loading run (B), volume-loaded V02-PVA relations at different E,, levels (C), V02-PVA relation in the inotropism run (D), and the relation between PVA-independent V02 and E.,, to determine oxygen cost of E.
(E). A shows LV systolic PVA in the P-V diagram. PVA consists of both potential energy (PE) and external work (EW) in an ejecting contraction and PE alone in an isovolumic contraction (see Fig. 3 ). PE and EW are energetically equivalent. B shows the volume-loaded V02-PVA relation in a baseline contractile state (thick dashed line) and V02 components. C shows the volume-loaded V02-PVA relations in the baseline contractile state and in altered contractile states (thick dashed diagonal lines). D shows an upward or downward deviation of a V02-PVA data point (solid circle) from a baseline V02-
PVA relation (open circle) with an increase or a decrease in Em., respectively, at a constant LV volume during each inotropism run. We called this steeper V02-PVA relation "the composite relation" (solid line). V02 of this point can be divided into two components: PVA-dependent V02 corresponding to the PVA of the contraction and PVA-independent V02, which is the sum of the same baseline PVA-independent V02 (equal to b in B) and the change in PVA-independent V02. E shows the relation between PVA-independent V02 and E,,,. The slope (c) ofthis relation is the oxygen cost ofcontractility in terms of Em., and the y-intercept (d) of this relation indicates the PVA-independent V02 extrapolated to zero Em. (see text for more details).
vided at the V02 intercept ofthe V02-PVA relation into PVAdependent and -independent V02 components ( Fig. 1 B) . PVA-independent V02 is considered to be primarily related to the total sequestered Ca2' by SR and basal metabolism (14,23). The V02-PVA relation is elevated in a parallel manner with an enhancement of E,,. ( Fig. 1 C) (14) . When E. is increased or decreased by a positive or negative inotropic intervention, respectively, at a constant LV volume, a V02-PVA point deviates upward or downward from a baseline V02-PVA relation and forms a new, steeper V02-PVA relation, which traverses multiple volume-loaded V02-PVA relations for different contractility levels (Fig. 1 D) . We call such a steeper V02-PVA relation obtained during changing inotropism "the composite relation" ( 19, 20) . In the inotropism run, PVA-independent V02 increases or decreases with an increase or de-crease in E.,,, respectively ( Fig. I E) ( 13, 14, 19) . The slope of the relation between the PVA-independent V02 and E.,z means the "oxygen cost ofcontractility" (Fig. 1 E) (20) . These features of the VO2-PVA-Em. relation have been thoroughly reviewed by Suga ( 14) . From the results of previous studies, it has been considered that the contractility-dependent changes in the PVA-independent V02 quantitatively reflect changes in energy expenditure for the total Ca2' handling in myocardium (13) (14) (15) (16) (17) (18) (19) (20) . This relation depends on the assumption of the stoichiometry that 1 mol of ATP is hydrolyzed for 2 mol of Ca2+ taken up by the Ca2+ pump ATPase ( 14, 16).
We hypothesized the effects of RYA on the composite relation as follows ( Fig. 2 ): If RYA changes contractility in a similar way to ordinary inotropic drugs by simply decreasing the total amount of Ca2" handling, the RYA-composite relation (shown by the diagonal solid arrow) will be superimposed on the same line as the CaCl2-composite relation (shown by the diagonal dashed arrow) ( Fig. 2 A) . In contrast, if the negative inotropism of RYA is mainly due to the open-fix effect on the Ca2+ release channel ofSR (9-1 1 ), the PVA-independent V02 will decrease very little whereas only the PVA-dependent V02 will decrease with reduced PVA. In this manner, V02 for each point on the composite relation will be higher than the originally expected value and, hence, the RYA-composite relation will be flatter than the CaCl2-composite relation (Fig. 2 B) .
Methods

Surgical preparation
Experiments were performed on the excised cross-circulated dog heart preparation as previously described in detail ( 13) . Briefly, two mongrel dogs ( 1 1-20 kg) were anesthetized with sodium pentobarbital (30 mg/ kg, i.v.) after premedication with ketamine hydrochloride (7 mg/kg, i.m.). Both dogs were heparinized (1,000 U/kg body wt). The heart donor dog (body wt 13.0±1.1 [SD] kg) was thoracotomized under artificial ventilation. The left subclavian artery and the right ventricle were cannulated and connected to the bilateral common carotid arteries and external jugular vein of the metabolic support dog ( 16.3±2.0 kg), respectively, with the cross-circulation tubes. All systemic and pulmonary vascular connections to the heart were ligated. The heart was excised from the chest after cross-circulation was started without an interruption of coronary perfusion.
The left atrium was opened and the chordae tendineae were cut. A rubber balloon with an unstressed volume of 60 ml was fitted into the LV chamber. The balloon was connected to our custom-made volume servo pump (International Servo Data, Tokyo, Japan) and primed with water. A miniature pressure gauge (P-7; Konigsberg Instruments, Inc., Pasadena, CA) was placed inside the apical end ofthe balloon to measure LV pressure.
The temperature of the heart was kept at 35-37°C with heaters. Heart rate was fixed constant in each heart at 145±9 (135-165) beats per min by left atrial pacing. Coronary arterial pH, P02, and Pco2 were repeatedly measured and corrected to normal as needed. for more details).
Contraction mode
We used isovolumic contractions in all of these runs. We consider that the contraction mode does not essentially affect the present results, as described in the "Theoretical considerations" section ( 14, 21, 24).
Oxygen consumption
Total coronary blood flow was measured with an electromagnetic flowmeter in the coronary venous cross-circulation tube. Coronary arteriovenous oxygen content difference (AV02D) was measured continuously with our custom-made oxygen content difference analyzer (model PWA-2005; Erma, Inc, Tokyo, Japan) ( 14). The oximeter was calibrated against an oxygen content analyzer (model IL-282 CO-Oximeter; Instrumention Laboratory, Lexington, MA). Cardiac oxygen consumption was obtained as the product of the total coronary blood flow and AVO2D. It was divided by heart rate to obtain V02 per beat in steady state. These computations were performed on-line with a signal processor (model 7T1 8; NEC San-ei, Tokyo, Japan). Right ventricular (RV) V02 was minimized by keeping the right ventricle collapsed with continuous hydrostatic drainage of the coronary venous return. The collapsed right ventricle was assumed to have virtually zero PVA and hence no PVA-dependent V02. The RV component of the PVA-independent V02 was calculated by multiplying biventricular PVA-independent V02 in each contractile state by (RV weight)/(LV + RV weight). PVA-independent LV V02 was then obtamned by subtracting the RV component from biventricular PVA-independent V02 in each contractile state. Postmortem LV weight (the LV free wall plus the septum) was 72.6±9.8 g. RV weight (the RV free wall only) was 21.7±5.1 g. RV/(LV + RV) weight ratio was 0.23±0.04.
Contractility index (E,,,,9 LV pressure (P(t)) and volume (V(t)) data were sampled at 2-ms intervals and processed with the signal processor. E,,. of the LV was determined as the ratio of P(t)/[V(t) -Vol] (25) . V0 is the volume at which peak isovolumic pressure and PVA are zero. The peak positive and negative values for the first derivative of LV pressure (max dP/dt and -max dP/dt, respectively) were determined. Time to E..x and time to -max dP/dt from the rising phase of R wave of epicardial electrocardiogram (ECG) were also determined. The time constant of left ventricular pressure decay during the isovolumic relaxation phase was determined by the method of Weiss et al. (26) . PVA As shown in Fig. 3 , we calculated PVA of each isovolumic beat from the digitized P(t) and V(t) data in the same way as before ( 13) . PVA is the area surrounded by the end-systolic PV relation line, the end-diastolic PV relation curve, and the vertical isovolumic pressure trajectory at the isovolumic volume. PVA was normalized for 100 g LV. Its dimensions are mmHg. ml* beat '~1I00 g -.
Blood pH and catecholamine measurements
We measured pH ofthe arterial blood in the coronary arterial perfusion tube before and during RYA infusion in five hearts. We also measured the concentration of catecholamines in the arterial blood before and during RYA in six hearts to eliminate the possibility that circulating catecholamines released from the support dog modified the inotropic effect of RYA. The analysis of catecholamines was performed in Otsuka Assay Laboratories of Otsuka Pharmaceuticals (Tokushima, Japan).
Experimental protocol
The experimental protocol consisted of three categories: The first category was "volume-loading runs" to obtain the volume-loaded V02-PVA relations. Steady state isovolumic contractions were produced at five to nine different LV volumes to cover a wide range of PVA in both the baseline contractility and depressed contractility level with RYA.
We called these runs the Baseline-VOL run and RYA-VOL run, respec- Each parameter was compared between baseline contractile state and the most depressed contractile state by RYA at the same LV volume. n, number of hearts subjected to analysis; CF, coronary blood flow; AVO2D, coronary arterio-venous oxygen content difference; +max (dp/dt), maximum positive value oftime-derivative of left ventricular pressure; -max (dp/dt), maximum negative value oftime-derivative of left ventricular pressure; time to -max (dp/dt) time from onset of R wave of ECG to -max (dp/dt). * P < 0.05 by paired t test.
Finally, the KCl-arrest run was performed when a new steady state was reached 20-30 min after all drug infusions were discontinued in 10 of the 11 hearts.
Data analysis
V02-PVA relation in VOL and INO runs. V02 and PVA data in Baseline-VOL run were subjected to linear-regression analysis to obtain a volume-loaded V02-PVA regression equation (Fig. 1 B) : V02 = aPVA + b, where a is the slope ofthe regression line and b is the V02 intercept. The reciprocal of the slope (1/a) means the contractile efficiency (13, 14) .
V02 and PVA data in each inotropism run were also subjected to linear-regression analysis to obtain a regression equation ofthe composite relation ( Fig. 1 D) (20) .
PVA-independent V02. The PVA-independent V02 ofa V02-PVA data point during the inotropism run was calculated as total V02 minus PVA-dependent V02. The PVA-dependent V02 was calculated as the product of the same slope value a as the baseline a and PVA of this contraction. Thus, the PVA-independent V02 at each altered contractility level was calculated as LV V02 minus aPVA.
Oxygen cost ofE,,. The relation between PVA-independent V02 and corresponding E. in each ofthe CaCl2-INO and RYA-INO runs was plotted in each heart (Fig. 1 E) . The slope (c) ofthe regression line was obtained in each run (20) . Its dimensions are ml 02 ml * mmHg-* beat -' *100 g-2. The y-intercept (d) of this regression line was obtained as the PVA-independent V02 extrapolated to zero E. (20) .
in each heart by analysis ofcovariance (ANCOVA). Significance ofthe differences in their slopes and elevations was tested by F test. AN-COVA was also applied to compare the regression lines of PVA-independent V02 on E. between CaCI2-INO and RYA-INO runs.
Comparisons of paired mean values were performed by paired t test. Comparisons ofmean values among three runs were performed by analysis of variance followed by the least significance difference method. A P value < 0.05 was considered statistically significant. Data are presented as mean±SD.
Results
Effect ofR YA on energetics and other parameters. Fig. 3 shows tracings of LV isovolumic pressure, volume, ECG, coronary flow, and AVO2D during the RYA-INO run at a constant LV volume in a representative heart, in which intracoronary RYA infusion rate was increased from 0 ( Fig. 3 A) to 0.67 nmol/min (Fig. 3 B) and to a maximum dose of 1.33 nmol/min ( Fig. 3  C) . This maximal dose was calculated to correspond to a blood concentration of -40 nM of RYA. RYA gradually depressed Enm from 4.7 to 2.2 mmHg * ml -I 100 g in 45 min. In this heart, the CaCl2-INO run preceding the RYA-INO run increased Em. from 4.6 to 7.6 mmHg. ml-' * 100 g. 42.1±14.8% (P < 0.001) and PVA by 44.4±15.3% (P < 0.001). However, RYA depressed V02 only by 7.4+12.1%; this decrease in V02 was not statistically significant. Coronary blood flow was unchanged during RYA whereas AVO2D slightly decreased (P < 0.05). RYA significantly depressed both max dP/dt and -max dP/dt (P < 0.001) and increased T,, (P < 0.01), time to -max dP/dt (P < 0.01), and -r (P < 0.05). Thus, RYA decreased the contraction speed and retarded the relaxation.
Comparison ofthe effects ofCaC12 and RYA on energetics. Fig. 4 compares composite relations in CaC12-INO and RYA-INO runs in the same heart as in Fig. 3 (Table II , No. 1). LV V02 increased linearly with increases in PVA in the CaCl2-INO run (r = 0.984). With decreases in E., by RYA, PVA decreased markedly from a pre-RYA level of 906 to 408 mmHg ml beat-' 100 g-', whereas V02 decreased only moderately from the pre-RYA level of 0.0402 to 0.0298 ml 02* beat -100 g-' . As a result, the RYA-composite relation (r = 0.985) rotated clockwise with a smaller slope and a greater V02 intercept compared with the CaCl2-composite relation. [9] [10] [11] were studied in the presence of propranolol. HR, constant heart rate. r, correlation coefficient of the V02-PVA relation. Slope, the slope of the V02-PVA regression line. VO2INT, PVA-independent V02. *Slope = the slope of the PVA-independent V02-Em,,, regression line. * VO2INT = PVA-independent V02 at 0 E.. Difference of the slope (SL) and the elevation (EL) of the regression lines were tested by F test (* P < 0.05, ** P < 0.01 ). *** P values <0.001 by paired t test.
The slope of the linear-regression line of the RYA-composite relation (2.22 x 0oml 02 mmHg' * ml-') was significantly smaller than that of the CaCl2-composite relation (3.84 x 10-5, P < 0.01, ANCOVA). Similar results were obtained in all other hearts regardless of ,-blockade. Numbers 9-1 1 corresponded to ,8-blockade hearts. The slope of the RYA composite relation was significantly smaller than that of the CaCl2 composite relation in 9 of the 11 hearts (AN-COVA). The other two hearts also showed smaller slope values, although the difference was not significant. The mean slope value was significantly smaller in the RYA-INO run (paired t test; P < 0.001 ). The mean V02-intercept value was significantly greater in the RYA-INO run than in the CaCl2-INO run and was also significantly greater than KCl-arrest V02 of0.0104±0.0022 ml 02 * beat'-l 100 g ' (analysis of variance, P < 0.001 ). The mean V02-intercept value in the CaCl2-INO run was not significantly different from KCl-arrest V02 (paired t test).
Comparison ofthe contractile efficiency between Baseline-VOL and R YA-VOL runs. Fig. 5 shows the V02-PVA relations obtained in Baseline-VOL (open squares) and RYA-VOL (closed circles) runs in a representative heart. Their slope values were not significantly different by ANCOVA. In all 11 hearts, the slope of the V02-PVA regression line was not significantly different between Baseline-VOL and RYA-VOL runs by ANCOVA (1.65±0.23 x 1-0 ml O2*mmHg' . ml-for Baseline-VOL run versus 1.54±0.22 X 10-5 ml 02 mmHg--ml[ for RYA-VOL run). The elevation difference between the two regression lines was statistically significant in 8 of 11 hearts (ANCOVA). Paired t test also showed a significantly smaller PVA-independent V02 in RYA-VOL run on the average (0.0255±0.0040 ml 02 * beat 100 g'l for Baseline-VOL run vs. 0.0229±0.0033 ml°2* beat-' . 100 g-' for RYA-VOL run, P < 0.01). Thus, the downward shift ofthe V02-PVA relation in the RYA-VOL run compared with the Baseline-VOL run was mainly a parallel shift. These results indicate that the contractile efficiency was not affected by RYA. Fig. 6 plots PVA-independent V02 against corresponding E., during CaCl2-INO and RYA-INO runs in the same heart as in Fig. 4 . In this heart, PVA-independent VO2 increased linearly with increases in En= with CaCl2 and decreased linearly with decreases in Em,, with RYA. The slope ofthe regression line was significantly smaller in RYA-INO runs (AN-COVA). These results indicate that in the RYA-INO run, PVA-independent V02 remained dispropotionately high despite the progressively decreased E.. Similar results were obtained in all the other 10 hearts (Table II, right) . ANCOVA showed significant difference in the slope between CaCl2-INO and RYA-INO runs in 9 ofthe 11 hearts. The mean slope value in the RYA-INO run was significantly lower than that in the CaCl2-INO run by 75.3±50.1% (P < 0.01). The PVA-independent V02 value in RYA-INO run was significantly greater by 150±143% (P < 0.001). pH and catecholamine measurements. pH of the arterial blood in the coronary arterial perfusion tube was 7.42±0.08 before RYA and 7.40±0.08 during 26± 10 nM RYA. The difference was not significant (paired t test).
The concentration of epinephrine in the arterial blood was 2.5±1.8 ng/ml before RYA and 2.8±1.8 ng/ml during RYA of 26±13 nM; norepinephrine was 0.74±0.65 ng/ml before RYA and 0.77±0.40 ng/ml during RYA. Thus, catecholamines in the arterial blood were not significantly changed by RYA. This result means the effect of RYA was not modified by effects of circulating catecholamines without complete ,B-blockade in our present study.
Discussion
Using RYA, we have obtained quite different results in cardiac energetics from those ofordinary inotropic drugs (13) (14) (15) (16) (17) (18) (19) (20) . The major findings ofthe present study are as follows: (a) RYA at a low concentration lowered both V02 and PVA linearly with decreases in ventricular contractility (Fig. 4) . (b) However, the magnitude of the change in V02 for a unit change in PVA was significantly smaller with RYA than with CaCl2 ( Fig. 4) . (c) The downward shift of the volume-loaded V02-PVA relation with RYA was a parallel shift ( Fig. 5 ). (d) PVA-independent V02 remained dispropotionately high despite the significantly decreased E. with RYA (Fig. 6) . These findings indicate that RYA does not proportionately decrease the nonmechanical V02 despite its potent negative inotropic effect and that RYA does not affect the contractile efficiency per se. In other words, the negative inotropic effect of RYA is accompanied by an oxygen-wasting effect in the nonmechanical energy utilization process of myocardium.
RYA and cardiac contractility. RYA at a low concentration (several tens of nM) has been shown to selectively bind the Ca2' release channels and fix them in a long-term open state with a reduced unit conductance (8-1 1 ), although RYA at a high concentration (above ,uM) fixes the channel in a close state. This feature of RYA is quite different from that of other Ca2' release channel regulators such as Ca2+, Mg2+, and ATP (8) (9) (10) (11) .
In the present study, we used RYA at a relatively low concentration (calculated value of 29±13 nM) and observed that RYA significantly depressed cardiac contractility. This finding is consistent with previous observations in isolated canine and cat cardiac muscles (27, 28) . In addition, RYA significantly slowed relaxation speed in terms of r and time to -max dP/dt (Table I) . From these findings, the conventional view that RYA increases the leak of Ca2+ from SR seems to hold in our present blood-perfused dog heart preparation.
RYA and PVA-independent V02. PVA-independent V02 reflects the VO2 fraction for nonmechanical activities, i.e., basal metabolism and excitation-contraction-relaxation coupling ( 14) . We consider that KCl-arrest VO2 is a reasonable estimate of the energy utilization for basal metabolism ( 14). Although KCl-arrest V02 was measured under a condition in which RYA remained in the cross-circulating blood, the value was comparable to those obtained in our previous studies ( 13, 14) . This suggests that RYA does not significantly affect energy utilization for basal metabolism and that the decreased PVAindependent V02 in RYA-INO run is mainly due to a decrease in the excitation-contraction-relaxation coupling energy.
In the present study, PVA-independent V02 gradually but significantly decreased with decreases in E.. by RYA (Fig. 6 ).
This result seems to reflect that RYA makes SR leaky for Ca2+ and decreases the Ca2+ store in SR (8) (9) (10) (11) (29) (30) (31) ). However, PVA-independent V02 remained dispropotionately high de- spite the significantly decreased E.., by RYA (Fig. 6 ). This indicates that total Ca2+ handling is not suppressed in proportion to the negative inotropism in the presence of RYA on the basis of the 2:1 stoichiometry of sequestered Ca2+ to hydrolyzed ATP by Ca2+ pump in SR (14, 32 (14, 20) . To explain the discrepancy of the findings between RYA and ordinary inotropic drugs, we raise the following possible subcellular mechanisms ofthe abnormal relation between the amount of total Ca2' handling and cardiac contractility with RYA. The gradually decreasing contractility with RYA at a low concentration can be explained by the view that SR gradually became leaky for Ca2' and, hence, the Ca2' accumulating activity ofSR decreases despite the continuous Ca2+ uptake into SR (29) (30) (31) . When Ca2+ leaks from SR, it would be taken up into SR by Ca2+ pump ATPase, which is an energy consuming process. We consider that this Ca2+ futile cycle was detected energetically as a disproportionate increase in PVA-independent V02 for a given contractility in the present study.
RYA and contractile efficiency. The contractile efficiency in terms ofthe inverse value ofthe slope ofthe V02-PVA relation was not changed by RYA (Fig. 5 ). This result means that energy using efficiency ofthe myofilament for force generation is not changed despite the changed Ca2' handling by RYA. This result seems to reflect the previous finding that RYA does not affect Ca2+ sensitivity of the myofilament from the relation between the steady state force and Ca2+ transient (33) .
Implications ofthe selective change in SR Ca2" releasefor cardiac contractility. Recent studies have indicated that dysfunction in Ca2+ transport system of SR has an important role in pathophysiological states such as ischemic, acidotic, and stunned hearts ( 1-7). It has been proposed that dysfunction of not only Ca2+ uptake (2, 5) but also Ca2' release (2-4) and Ca2+ permeability ofthe SR ( 1 ) contribute to this SR dysfunction. Feher et al. (4) have shown that the decrease in SR Ca2+ uptake caused by ischemia is not due to a defect in the SR Ca2+ pumping capability but is due to an increased efflux through the SR Ca2' release channel.
However, in such pathological states, there are other subcellular mechanisms altering cardiac contractile function at the same time (3, 7, 34, 35) . For example, ischemia decreases the adenine nucleotide pool (34) and damages contractile protein and cell membranes (7) and acidosis changes Ca2+ sensitivity of the myofilament (3, 35) . It is difficult to clarify the magnitude of contribution of each of these subcellular mechanisms on contractile dysfunction in such pathological preparations.
In contrast, we were able to characterize the energetic role ofthe selective change in SR Ca2' release on cardiac mechanoenergetics when the Ca2' release channel activity was selectively modified without changes in other subcellular mechanisms, including changes in Ca2+ uptake activity ofCa 2+ pump ATPase (2, 5) . In conclusion, we have indicated the importance of the effect of a change in SR Ca2' release on the contractile dysfunction as observed in pathological hearts.
